Faculdade de Medicina de São José do Rio Preto-SP (FAMERP) - Hospital de Base (HB)
Faculdade de Medicina de São José do Rio Preto-SP (FAMERP) - Hospital de Base (HB)
Av. Brg. Faria Lima, 5544 - Vila Sao Jose, São José do Rio Preto - SP, 15090-000, Brazil
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Danielle Frassatto
Cassia Regina Pradela CIP
Geni Cunrath
Giovana Dalmedico de Castro
Keulle Torres Candido
Gil Carvalho
Tatiane Oiafuso
Cristiani Butinhao
Lilian Marcela Santana Pinho
Juliane Peres Garcia
Natália Parra Gonzales
Lilia Nigro Maia
Jaqueline Mastro
Thais Garcia
Angélica Belasco
Osana Maria Costa
Fernanda Pinhel
Cassia Regina Pradela
Elaine Bustamante Gallo
Thaise Pontana
Rita de Cassia Martins Alves Da Silva
Jemima Domingos Lemes
Debora Dada Martineli Torres
Cristiani Fernanda Butinhao
Edla Polsinelli Bedin Mascarin do Vale
Juliane Garcia
Ana Affonso
Katia Nishiyama
Raissa Mendes
Mariana Martins P.
Juliana Vieira Garcia
Flavia Funes
Osvaldo Lourenço da Silva Jr. null
João Daniel Cardoso Guedes
Nadielly Goes
Open studies
Lung cancer
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC - ALKAZAR - Nuvalent Inc.See more
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023] - MK-2870-023 - Merck Sharp & Dohme LLCSee more
A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer) - TROPICAL-1 - Latin American Cooperative Oncology GroupSee more
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) - CodeBreaK 202 - AmgenSee more
Breast Cancer
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy - INAVO121 - Hoffmann-La RocheSee more
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) - MK-2870-032 - Merck Sharp & Dohme LLCSee more
Obesity
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity - MARITIME-HF - AmgenSee more
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
Steatohepatitis
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis - LIVERAGE - Cirrosis - Boehringer IngelheimSee more
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis - LIVERAGE - Boehringer IngelheimSee more
Prostate cancer
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) - IDeate-Prostate01 - Merck Sharp & Dohme LLCSee more
Heart failure
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity - MARITIME-HF - AmgenSee more
Chronic obstructive pulmonary disease
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006) - EMBARK - AstraZenecaSee more
Head and neck cancer
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC - NANORAY-312 - NanobiotixSee more
Cirrhosis
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis - LIVERAGE - Cirrosis - Boehringer IngelheimSee more
Colorectal cancer
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation - CodeBreaK 301 - AmgenSee more
Cardiovascular disease
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
Ulcerative colitis
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis - SUNSCAPE-1 - SanofiSee more
Crohn's disease
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease - STARSCAPE-1 - SanofiSee more
Pneumonia
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) - ESsCAPE - BiotestSee more
